ATRS

Antares Pharma, Inc.
ATRS

Overview Fund Activity
Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

67 hedge funds and large institutions have $86.2M invested in Antares Pharma, Inc. in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 14 closing their positions.

Holders
67
Holders Change
-4
Holders Change %
-5.63%
% of All Funds
1.79%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
10
Increased
16
Reduced
23
Closed
14
Calls
$105K
Puts
–
Net Calls
+$105K
Net Calls Change
+$120K

Top Buyers

1
PCM
1
Perkins Capital Management
Minnesota
$1.02M
2
CCM
2
Courage Capital Management
Tennessee
$1.57M
3
JAM
3
JW Asset Management
Florida
$1.41M
4
KCM
4
Kingdon Capital Management
New York
$2.73M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$9.07M

Top Sellers

1
AC
1
Armistice Capital
New York
$20.7M
2
WHI
2
William Harris Investors
Illinois
$67K
3
PLP
3
Pleasant Lake Partners
Puerto Rico
$578K
4
PP
4
Paloma Partners
Connecticut
$0
5
CS
5
Credit Suisse
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
OAM
76
Oxford Asset Management
United Kingdom
– -$49K -47,032 Closed
DCM
77
DAFNA Capital Management
California
– -$47K -45,000 Closed
TSS
78
Two Sigma Securities
New York
– -$22K -20,609 Closed
Two Sigma Advisers
79
Two Sigma Advisers
New York
– -$21K -20,300 Closed
Barclays
80
Barclays
United Kingdom
– -$19K -18,125 Closed
SI
81
SII Investments
Wisconsin
– -$11K -10,100 Closed
PNC Financial Services Group
82
PNC Financial Services Group
Pennsylvania
– -$1K -675 Closed
1 2 3
4